The fightn-CKD Study is testing an investigational drug to see whether it could help people with high blood pressure (hypertension) and chronic kidney disease (CKD). A high dose and a low dose of the investigational drug will be compared with a placebo. A placebo looks exactly like the investigational drug but contains no active medication.
The investigational drug is designed to block the production of a hormone, called aldosterone, which is linked to hypertension. Researchers believe that lowering aldosterone levels could help reduce blood pressure and improve kidney function.
Primary Study Coordinator: Diann
e-mail: dmoore@obfmc.com
Phone: (662) 893-8490 Extension *3231